Trial intelligence / Profile preview

Remimazolam besylate amnesia effect trial in adults undergoing painless gastroscopy

ChiCTR2300076172Phase 4Recruiting

Sponsor
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Remimazolam Besylate with Propofol (2 arms). Primary endpoint: Incidence of complete anterograde amnesia. Started Sep 2023; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on ChiCTR2300076172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call